Marathon Fusion Plans to Co-Produce Gold and Medical Isotopes
Kyle Schiller explains why Marathon Fusion targets medical isotopes and gold co-production while doubling reactor power density each month.
10+ hours of podcasts, in 5 minutes.
John Coogan and Jordi Hays discuss Moderna's leaked cancer trial results and a bizarre influencer options trade, before interviewing Summit Sotheby's CEO Thomas Wright on luxury Western real estate dynamics and AI listing controversies. They then host Kyle Schiller of Marathon Fusion on producing medical isotopes and gold alongside fusion power, followed by Steven Schwartz detailing Whop's $205 million funding round, and end on Palmer Luckey and Ben Lamb's bioengineered defense venture, Warhound.
Kyle Schiller explains why Marathon Fusion targets medical isotopes and gold co-production while doubling reactor power density each month.
Moderna stock dropped 18% after clinical trial data leaked. John Coogan breaks down the gap between medical wins and market expectations.
Steven Schwartz explains how Whop raised $205 million by stacking micro-markets, pitching Doug Leone, and building tools to make solopreneurs money.
10+ hours of podcasts, distilled into one 5-minute read. Free, every Sunday.
For now, every subscriber gets both newsletters. No spam. Unsubscribe with one click.